Beta Drugs Q1 Results
- BSE: -
- NSE: BETA
- ISIN: INE351Y01019
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
2,118.50
32.70 (1.57%)
32.70 (1.57%)Volume18.07 K
Updated: Fri 11 Sep, 2026 | 15:29:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹125.55 Cr.(25.29%)
- Operating Profit₹23.02 Cr.(44.07%)
- Profit After Tax₹15.80 Cr.(35.07%)
- Operating Margin18.34%(14.99%)
Note: Comparison is on YoY basis
Quarterly - Beta Drugs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 25 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 102.53 | 81.08 | 26.45% | 84.23 | 21.73% |
| Depreciation/ Amortization | 4.35 | 4.80 | -9.42% | 3.73 | 16.62% |
| Operating Income | 23.02 | 12.88 | 78.72% | 15.98 | 44.07% |
| Net Income | 15.80 | 9.05 | 74.63% | 11.70 | 35.07% |
| Other Operating Expenses Total | 23.27 | 21.51 | 8.17% | 2.87 | 710.68% |
| Net Income Before Taxes | 22.04 | 11.83 | 86.30% | 15.65 | 40.87% |
| Total Revenue | 125.55 | 93.96 | 33.61% | 100.21 | 25.29% |
| Selling/ General/ Admin Expenses Total | 20.40 | 18.68 | 9.20% | 2.74 | 643.63% |
| Diluted Normalized EPS | 14.78 | 8.92 | 65.64% | 15.45 | -4.33% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.